Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|October 6, 2015
Short-Term Challenges for Specialty Pharmacy
Author(s)Davy James, Managing Editor
Joseph Morse, president and chief operating officer of Therigy, LLC, discusses significant challenges in over the next five years in specialty pharmacy.
Advertisement
Joseph Morse, president and chief operating officer of Therigy, LLC, discusses significant challenges in over the next five years in specialty pharmacy.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
4
Building a BCMA Bispecific Around the Patient Experience, Not Just the Molecule
5